The Rumors Were True: Abbott Buys St. Jude For $25b To Create Third Cardiovascular Giant
This article was originally published in Clinica
Executive Summary
Abbott Laboratories has agreed to acquire St. Jude Medical for $25bn, creating a third player, along with Boston Scientific and Medtronic, that competes in all major sectors of the cardiovascular device business.